Profit

GlaxoSmithKline management on the open offer for GSK Pharma

PUBLISHED ON: December 16, 2013 | Duration: 3 min, 20 sec

  
loading..
David Redfern, chief strategy officer at GlaxoSmithKline speaks to NDTV about the Rs 6,400 crore open offer for GSK Pharma and the reasons behind the company's decision to up its stake in its India unit.
ALSO WATCH
GSK Consumer offer very good; Ranbaxy Lipitor recall to hurt

................................ Advertisement ................................

................................ Advertisement ................................